Presentation is loading. Please wait.

Presentation is loading. Please wait.

Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin  Russell H.

Published bySylwester Krzemiński Modified over 5 years ago

Similar presentations

Presentation on theme: "Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin  Russell H."— Presentation transcript:

1 Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin  Russell H. Samson, Ricardo Morales, David P. Showalter, Michael R. Lepore, Deepak G. Nair  Journal of Vascular Surgery  Volume 63, Issue 1, (January 2016) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig 1 Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

3 Fig 2 Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

Download ppt "Five-Year Patency Rates for Heparin-Bonded Expanded Polytetrafluoroethylene Femoropopliteal Bypass Grafts vs ePTFE Grafts Without Heparin  Russell H."

Similar presentations

Richard M. Green, MD, William M

Richard M. Green, MD, William M
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon- coated polytetrafluoroethylene vascular grafts  James Laredo, MD, PhD,

Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon- coated polytetrafluoroethylene vascular grafts  James Laredo, MD, PhD,
A durable iliac-axillary and axillary-carotid bypass for cerebral ischemia due to Takayasu arteritis allowed successful pregnancies and deliveries  Norihiro.

A durable iliac-axillary and axillary-carotid bypass for cerebral ischemia due to Takayasu arteritis allowed successful pregnancies and deliveries  Norihiro.
The Efficacy of New VEINOPLUS Stimulation Technology to Increase Venous Flow and Prevent Venous Stasis  M.B. Griffin, A.N. Nicolaides, D. Bond, G. Geroulakos,

The Efficacy of New VEINOPLUS Stimulation Technology to Increase Venous Flow and Prevent Venous Stasis  M.B. Griffin, A.N. Nicolaides, D. Bond, G. Geroulakos,
Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia  Hani Slim, MD, MRCS, Alok Tiwari,

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia  Hani Slim, MD, MRCS, Alok Tiwari,
Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis.

Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis.
Howard E. Katzman, MD, Robert B. McLafferty, MD, John R

Howard E. Katzman, MD, Robert B. McLafferty, MD, John R
Thoracofemoral Bypass Through a Transdiaphragmatic, Retronephric Tunnel With Concomitant Tibial Bypass for Limb Salvage  Benjamin Keyser, DO, Melissa.

Thoracofemoral Bypass Through a Transdiaphragmatic, Retronephric Tunnel With Concomitant Tibial Bypass for Limb Salvage  Benjamin Keyser, DO, Melissa.
Vascular access in hemodialysis patients older than 80 years

Vascular access in hemodialysis patients older than 80 years
The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery  Jasper van der Slegt, MD, Stijn L. Steunenberg,

The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery  Jasper van der Slegt, MD, Stijn L. Steunenberg,
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,
Femoropopliteal prosthetic bypass graft infection due to Mycobacterium abscessus localized by FDG-PET/CT scan  Michael D. Marion, MD, Mark K. Swanson,

Femoropopliteal prosthetic bypass graft infection due to Mycobacterium abscessus localized by FDG-PET/CT scan  Michael D. Marion, MD, Mark K. Swanson,
Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia  Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,

Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia  Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Safety and efficacy of a modified HeRO dialysis device in achieving early graft cannulation: A single-institution experience  John W. Perry, BS, David.

Safety and efficacy of a modified HeRO dialysis device in achieving early graft cannulation: A single-institution experience  John W. Perry, BS, David.
Michael J. Singh, MD, Ronald Fairman, MD, Paul Anain, MD, William D

Michael J. Singh, MD, Ronald Fairman, MD, Paul Anain, MD, William D

Similar presentations

Ads by Google